Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

DNA vaccines for prostate cancer.

Zahm CD, Colluru VT, McNeel DG.

Pharmacol Ther. 2017 Jun;174:27-42. doi: 10.1016/j.pharmthera.2017.02.016. Epub 2017 Feb 7. Review.

PMID:
28185916
2.

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.

Colluru VT, McNeel DG.

Oncotarget. 2016 Oct 18;7(42):67901-67918. doi: 10.18632/oncotarget.12178.

3.

Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1).

Lee SH, Carrero JA, Uppaluri R, White JM, Archambault JM, Lai KS, Chan SR, Sheehan KC, Unanue ER, Schreiber RD.

J Immunol. 2013 Oct 15;191(8):4223-34. doi: 10.4049/jimmunol.1300910. Epub 2013 Sep 18.

4.

The timing of IFNβ production affects early innate responses to Listeria monocytogenes and determines the overall outcome of lethal infection.

Pontiroli F, Dussurget O, Zanoni I, Urbano M, Beretta O, Granucci F, Ricciardi-Castagnoli P, Cossart P, Foti M.

PLoS One. 2012;7(8):e43455. doi: 10.1371/journal.pone.0043455. Epub 2012 Aug 17.

5.

Early events regulating immunity and pathogenesis during Listeria monocytogenes infection.

Williams MA, Schmidt RL, Lenz LL.

Trends Immunol. 2012 Oct;33(10):488-95. doi: 10.1016/j.it.2012.04.007. Epub 2012 Jun 5. Review.

6.

Clinical development of Listeria monocytogenes-based immunotherapies.

Le DT, Dubenksy TW Jr, Brockstedt DG.

Semin Oncol. 2012 Jun;39(3):311-22. doi: 10.1053/j.seminoncol.2012.02.008. Review.

7.

The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.

Barberi TJ, Dunkle A, He YW, Racioppi L, Means AR.

PLoS One. 2012;7(1):e29808. doi: 10.1371/journal.pone.0029808. Epub 2012 Jan 4.

8.

CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes.

Edelson BT, Bradstreet TR, Hildner K, Carrero JA, Frederick KE, KC W, Belizaire R, Aoshi T, Schreiber RD, Miller MJ, Murphy TL, Unanue ER, Murphy KM.

Immunity. 2011 Aug 26;35(2):236-48. doi: 10.1016/j.immuni.2011.06.012.

Supplemental Content

Support Center